Metformin administration to induced-T1DM mice decreased blood glucose levels, while increased EPCs numbers (Dil-acLDL+ FITC‐UEA‐I+ Sca-1+ Flk-1+) and improved in vivo wound healing and angiogenesis [167]. This evidence concerns the gene KDR and type 1 diabetes mellitus.